Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2015 | 2014 |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

1998 – 2000 Research Grants

Michael J. Tisdale, DSc., Ph.D.
Mechanism of Muscle Protein Catabolism in Cancer Cachexia
Ashton University, United Kingdom

Hava Avraham Ph.D.
Studies of CHK Kinase in Pancreatic Cancer Cells
Beth Israel Deaconess Medical Center

Thomas Adrian, Ph.D.
LOX Inhibitors for Pancreatic Cancer Treatment and Prevention
Creighton University School of Medicine

Douglas Tyler, M.D.
Immunotherapy of Pancreatic Cancer Using Dendritic Cells Pulsed with Antigen in the Form of Amplified Total Tumor R
Duke University Medical Center

Eric J. Duell, Ph.D.
Gene-Environment Interactions in Pancreatic Adenocarcinoma
Harvard School of Public Health

Michael G. Goggins, M.D.
Proteomic Profiles of Pancreatic Cancer
Johns Hopkins University 

Constance Griffin, M.D.
Chromosome Analysis in Patients with Familial Pancreatic Cancer
Johns Hopkins University 

Gloria Huei-Ting Su, Ph.D.
Mouse Models for Human Pancreatic Cancer
Johns Hopkins University 

Elizabeth Jaffee, M.D.
A Phase II Study of an Allogeneic Gm-CSF Secreting Pancreatic Tumor Vaccine
Johns Hopkins University

Steven D. Leach, M.D.
Notch Signaling in Pancreatic Cancer Precursors
Johns Hopkins University 

Gloria M. Peterson, Ph.D.
Genetic Epidemiology of Pancreatic Cancer
Mayo Clinic at Rochester

Yuman Fong, M.D.
Synergy of Herpes Viruses with Chemotherapy or Immunotherapy in the Treatment of Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center

Josef Michl, M.D.
Matthew R. Pincus, M.D., Ph.D.
Novel Methods in the Diagnosis and Treatment of Pancreatic Cancer
SUNY Downstate Medical Center

David T. Curiel, M.D.
Pancreatic Carcinoma Specific Replicative Adenoviral Agent
University of Alabama at Birmingham

David McConkey, M.D.
Identifying Suitable Screening Tests to Detect Early Symptom-less Pancreatic Cancer
University of Texas M.D. Anderson Cancer Center

Keping Xie, M.D., Ph.D.
Control of Pancreatic Cancer Metastasis by Modulating Tumor-associated Nitric Oxide Production
University of Texas M.D. Anderson Cancer Center

Margaret Tempero, M.D.
Optimizing Therapy for Pancreatic Adenocarcinoma with TALL-104 Cells
University of Nebraska

David C. Whitcomb, M.D., Ph.D.
Identify Genes Which are Only Expressed in Pancreatic Cancer Cells
University of Pittsburgh

James Freeman, Ph.D.
TGF-B Type II Receptor Gene as a Target for the Antitumor Effect of Farnesyltransferace Inhibitors in Pancreatic Cancer
University of Texas at San Antonio

Shrikanth A. G. Reddy, Ph.D.
AP-1 and Ras Signaling in Pancreatic Cancer Cells
University of Texas M.D. Anderson Cancer Center

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303